HPV and Human Cancer: A prevention success and a therapeutic opportunity
Despite the extraordinary effectiveness of the current HPV VLP based vaccines in prevention they have no therapeutic value. Individuals already infected by a cancer associated HPV type are still at risk fro developing cancer. Dr Howley’s lab has been studying the pathway by which HPV targets p53 proteolysis with the goal of uncovering a therapeutic strategy.
Date:
17 October 2017, 13:00 (Tuesday, 2nd week, Michaelmas 2017)
Venue:
NDM Building, Headington OX3 7FZ
Venue Details:
Basement seminar room, TDI
Speaker:
Peter Howley (Harvard)
Organising department:
Ludwig Institute for Cancer Research, Oxford Branch
Organiser:
Christina Woodward (Oxford Ludwig Institute, Nuffield Department of Medicine, University of Oxford)
Organiser contact email address:
christina.woodward@ludwig.ox.ac.uk
Host:
Prof Xin Lu (Ludwig Cancer Research, Oxford Branch)
Part of:
Ludwig Institute Seminar Series
Topics:
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Christina Woodward
